Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.3B | 1.2B | 1.2B | 1.3B |
Cost of revenue | 1.2B | 1.1B | 1.1B | 1.2B |
Gross profit | 92.4M | 103.1M | 75.6M | 105.5M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 95.6M | 102.6M | 91.0M | 106.4M |
Other operating expenses | 6.9M | -156.4M | 8.1M | 37.5M |
Operating income | 29.6M | 13.6M | 8.5M | 70.4M |
Non operating interest income | ||||
Income | 10.5M | -23.0M | 163K | 8.6M |
Expense | 29.2M | 4.7M | 16.8M | 25.3M |
Other income expense | — | — | — | — |
Pretax income | 10.3M | 46.0M | -8.6M | 53.0M |
Tax provision | 2.1M | -44.6M | 11.0M | 11.8M |
Net income | 8.2M | 90.6M | -19.7M | 41.2M |
Basic EPS | 0.0 | — | -0.1 | 0.2 |
Diluted EPS | 0.0 | — | -0.1 | 0.2 |
Basic average shares | 202M | — | 202M | 202M |
Diluted average shares | 202M | — | 202M | 202M |
EBITDA | 50.2M | 91.0M | 49.0M | 145.0M |
Net income from continuing op. | 8.2M | 46.0M | -8.6M | 55.8M |
Minority interests | -2.3M | -3.1M | -2.7M | -2.3M |
Preferred stock dividends | 0 | 0 | 0 | 0 |